Cargando…

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern

The ongoing COVID‐19 pandemic and the emergence of new SARS‐CoV‐2 variants of concern (VOCs) requires continued development of effective therapeutics. Recently, we identified high‐affinity neutralizing nanobodies (Nbs) specific for the receptor‐binding domain (RBD) of SARS‐CoV‐2. Taking advantage of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wagner, Teresa R, Schnepf, Daniel, Beer, Julius, Ruetalo, Natalia, Klingel, Karin, Kaiser, Philipp D, Junker, Daniel, Sauter, Martina, Traenkle, Bjoern, Frecot, Desiree I, Becker, Matthias, Schneiderhan‐Marra, Nicole, Ohnemus, Annette, Schwemmle, Martin, Schindler, Michael, Rothbauer, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811630/ https://www.ncbi.nlm.nih.gov/pubmed/34927793 http://dx.doi.org/10.15252/embr.202153865

Ejemplares similares

NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies
por: Wagner, Teresa R, et al.
Publicado: (2021)

30 Jahre Nanobodies: Neues von kleinen Helfern mit großem Potenzial
por: Wagner, Teresa R., et al.
Publicado: (2023)

Monitoring extracellular ion and metabolite dynamics with recombinant nanobody-fused biosensors
por: Burgstaller, Sandra, et al.
Publicado: (2022)

COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants
por: Junker, Daniel, et al.
Publicado: (2022)

A peptide tag-specific nanobody enables high-quality labeling for dSTORM imaging
por: Virant, David, et al.
Publicado: (2018)

Improved targeting of human CD4(+) T cells by nanobody-modified AAV2 gene therapy vectors
por: Hamann, Martin V., et al.
Publicado: (2021)

A Nanobody-Based Toolset to Monitor and Modify the Mitochondrial GTPase Miro1
por: Fagbadebo, Funmilayo O., et al.
Publicado: (2022)

Peptides in headlock – a novel high-affinity and versatile peptide-binding nanobody for proteomics and microscopy
por: Braun, Michael B., et al.
Publicado: (2016)

An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants
por: Chi, Xiaojing, et al.
Publicado: (2022)

Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2
por: Pymm, Phillip, et al.
Publicado: (2022)

IFN-λ is protective against lethal oral Toxoplasma gondii infection
por: Murillo-León, Mateo, et al.
Publicado: (2023)

Under the Microscope: Single-Domain Antibodies for Live-Cell Imaging and Super-Resolution Microscopy
por: Traenkle, Bjoern, et al.
Publicado: (2017)

Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
por: Becker, Matthias, et al.
Publicado: (2021)

Real-time analysis of epithelial-mesenchymal transition using fluorescent single-domain antibodies
por: Maier, Julia, et al.
Publicado: (2015)

A multivalent biparatopic EGFR-targeting nanobody drug conjugate displays potent anticancer activity in solid tumor models
por: Fan, Jiansheng, et al.
Publicado: (2021)

A novel epitope tagging system to visualize and monitor antigens in live cells with chromobodies
por: Traenkle, Bjoern, et al.
Publicado: (2020)

Special Issue: Nanobody
por: Chames, Patrick, et al.
Publicado: (2020)

Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination
por: Dulovic, Alex, et al.
Publicado: (2022)

Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients
por: Becker, Matthias, et al.
Publicado: (2022)

Enhancement of Polymeric Immunoglobulin Receptor Transcytosis by Biparatopic VHH
por: Emmerson, Chris D., et al.
Publicado: (2011)

A Strategy to Optimize the Generation of Stable Chromobody Cell Lines for Visualization and Quantification of Endogenous Proteins in Living Cells
por: Keller, Bettina-Maria, et al.
Publicado: (2019)

Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4(+) Cancers
por: Cano-Garrido, Olivia, et al.
Publicado: (2021)

Nanobodies Right in the Middle: Intrabodies as Toolbox to Visualize and Modulate Antigens in the Living Cell
por: Wagner, Teresa R., et al.
Publicado: (2020)

Expeditious Generation of Biparatopic Common Light Chain Antibodies via Chicken Immunization and Yeast Display Screening
por: Bogen, Jan P., et al.
Publicado: (2020)

Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis
por: Strengert, Monika, et al.
Publicado: (2021)

Impaired immune response drives age-dependent severity of COVID-19
por: Beer, Julius, et al.
Publicado: (2022)

Structural insights into the mechanism of action of a biparatopic anti-HER2 antibody
por: Oganesyan, Vaheh, et al.
Publicado: (2018)

Engineering an anti-HER2 biparatopic antibody with a multimodal mechanism of action
por: Kast, Florian, et al.
Publicado: (2021)

Single-Domain Antibodies for Targeting, Detection, and In Vivo Imaging of Human CD4(+) Cells
por: Traenkle, Bjoern, et al.
Publicado: (2021)

A biparatopic agonistic antibody that mimics fibroblast growth factor 21 ligand activity
por: Shi, Sally Yu, et al.
Publicado: (2018)

HDX-MS for Epitope Characterization of a Therapeutic ANTIBODY Candidate on the Calcium-Binding Protein Annexin-A1
por: Gramlich, Marius, et al.
Publicado: (2021)

Generation of an alpaca-derived nanobody recognizing γ-H2AX
por: Rajan, Malini, et al.
Publicado: (2015)

Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany
por: Dulovic, Alex, et al.
Publicado: (2022)

A Tetravalent Biparatopic Antibody Causes Strong HER2 Internalization and Inhibits Cellular Proliferation
por: Benedetti, Filippo, et al.
Publicado: (2021)

Biparatopic sybodies neutralize SARS‐CoV‐2 variants of concern and mitigate drug resistance
por: Walter, Justin D, et al.
Publicado: (2022)

Targeted Fcγ Receptor (FcγR)-mediated Clearance by a Biparatopic Bispecific Antibody
por: Kasturirangan, Srinath, et al.
Publicado: (2017)

An anti-HER2 biparatopic antibody that induces unique HER2 clustering and complement-dependent cytotoxicity
por: Weisser, Nina E., et al.
Publicado: (2023)

Molecular Mechanism of HER2 Rapid Internalization and Redirected Trafficking Induced by Anti-HER2 Biparatopic Antibody
por: Cheng, Jackie, et al.
Publicado: (2020)

Potent Neutralization of Omicron and other SARS-CoV-2 Variants of Concern by Biparatopic Human VH Domains
por: Chen, Chuan, et al.
Publicado: (2022)

TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity
por: Ugamraj, Harshad S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_quj2jg5n9ppgavi33lt519hki4